TP53 and colorectal carcinoma: Importantly, however, in patient-derived organoids (PDOs), a clinically relevant translational model system generated from a CRC liver metastasis with wild-type p53, Palbociclib in combination with Ganetespib strongly diminished organoid viability and size (Fig. 5G).